3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33773404 | SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner. | 2021 Jun | 2 |
| 2 | 32269620 | SET and MYND domain-containing protein 3 inhibits tumor cell sensitivity to cisplatin. | 2020 May | 10 |
| 3 | 32705243 | SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer. | 2020 Sep | 1 |